動物用皮膚科医薬品の世界市場

動物用皮膚科医薬品の世界市場は2030年までに276億米ドルに達する見込み

2024年に168億米ドルと推定される動物用皮膚科医薬品の世界市場は、2024～2030年の分析期間においてCAGR 8.6%で成長し、2030年には276億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである寄生虫感染症は、CAGR 8.1%を記録し、分析期間終了時には162億米ドルに達すると予測されます。アレルギー性感染症分野の成長率は、分析期間中CAGR 9.8％と推定されます。

米国市場は46億米ドルと推定、中国はCAGR13.2％で成長予測

米国の動物用皮膚科医薬品市場は、2024年に46億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに60億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.4%と8.2%と予測されています。欧州では、ドイツがCAGR 5.7%で成長すると予測されています。

世界の動物用皮膚科医薬品市場- 主要動向と促進要因まとめ

なぜ動物用皮膚科医薬品の需要が急増しているのか？

動物用皮膚科医薬品市場は、コンパニオンアニマルや畜産動物における皮膚疾患の有病率の増加により、かつてない需要の急増を目の当たりにしています。アレルギー性皮膚炎、膿皮症、疥癬、真菌感染症などの皮膚疾患が蔓延しており、ペットの飼い主や畜産農家は効果的な治療法を求めざるを得なくなっています。動物の健康に対する飼い主の意識の高まり、獣医療へのアクセスの改善、ペットの人間化の傾向の高まりといった動向はすべて、この需要増に寄与しています。さらに、診断ツールや遠隔医療プラットフォームの進歩により、獣医師が皮膚疾患を早期に診断するケースが増えており、処方箋に基づく治療が増加しています。コンパニオンアニマル、特に犬や猫は、環境汚染物質、食物過敏症、寄生虫感染による皮膚アレルギーに悩まされ、皮膚科治療薬の需要をさらにエスカレートさせています。さらに、畜産農家は動物の福祉と生産性を優先しており、皮膚感染症が乳量、肉質、全体的な動物の健康に大きな影響を与えることを認識しています。このような需要は、特にペットの飼育数が過去最高となっている先進地域を中心に、世界のペット数の増加によってさらに高まっています。人獣共通感染症の認識が高まるにつれ、動物と人間の健康維持における皮膚科治療の重要性が注目されています。これらの要素が相まって、特殊な動物用皮膚科医薬品の市場が拡大し、製薬企業にとって有利な分野となっています。

動物用皮膚科医薬品における最先端のイノベーションとは？

製薬会社は、治療効果を高める革新的でより効果的な動物用皮膚科医薬品を導入するため、研究開発に多額の投資を行っています。この分野で最も画期的な進歩のひとつは、ペットのアレルギー性皮膚炎やアトピー性皮膚炎に的を絞った治療を提供するモノクローナル抗体療法の開発です。このような生物学的製剤による治療は、従来のコルチコステロイドや抗ヒスタミン剤に比べ、副作用が少なく、緩和効果が長く持続することから、大きな支持を得ています。さらに、ヤヌスキナーゼ（JAK）阻害剤のような新規の低分子阻害剤への関心が高まっており、動物の炎症性皮膚疾患の治療法に革命をもたらしつつあります。これらの阻害剤はアレルギー反応に関与する特定のサイトカイン経路を効果的にブロックし、副作用を最小限に抑えた精密な治療を提供します。また、動物用皮膚科領域では、抗菌ペプチドや天然生理活性化合物を配合した薬用シャンプー、スプレー、軟膏などの局所用薬剤製剤の台頭が見られ、感染症の治療と同時に皮膚のバリア保護を強化しています。さらに、ナノテクノロジーを駆使したドラッグ・デリバリー・システムは、皮膚科治療のバイオアベイラビリティと有効性を改善するために研究されています。もうひとつの注目すべき動向は、プロバイオティクスや微生物ベースの治療法の台頭です。これらは、動物の皮膚上の微生物集団を調節することにより、皮膚の恒常性を回復させることを目的としています。遺伝子治療と再生医療の進歩は、まだ実験段階であるが、特定の犬種における遺伝性皮膚疾患への対処に有望です。これらの最先端の技術革新は、獣医皮膚科学におけるパラダイムシフトを反映しており、対症療法から治療・予防的アプローチへとシフトしています。

規制政策と市場力学はどのように業界を形成しているか？

規制状況と市場力学は、この分野の成長軌道を形成する上で極めて重要な役割を果たしています。動物用医薬品を取り巻く厳しい規制、特に米国と欧州連合（EU）では、医薬品開発と承認プロセスにおける精査の強化につながっています。米国食品医薬品局（FDA）や欧州医薬品庁（EMA）といった機関は、動物用医薬品の安全性、有効性、品質を確保するために厳格な基準を課しています。規制遵守は多くのメーカーにとって依然として課題であるが、臨床試験済みで十分な文書化された治療法のみが市場に出回ることを保証し、消費者の信頼を高めています。市場力学は、動物用医薬品企業の統合によってさらに影響を受け、主要企業間の競争が激化しています。大企業は、製品ポートフォリオを拡大し競争優位を得るために、皮膚科学的ソリューションを専門とする中小バイオテクノロジー企業を積極的に買収しています。さらに、eコマースや動物用医薬品の直販の影響力の高まりは、こうした製品の流通方法を変えつつあります。オンライン動物薬局やペットヘルスケアプラットフォームは、ペットの飼い主にとって皮膚科治療薬をより身近なものにし、従来の動物病院への依存を減らしています。市場力学に影響を与えるもう一つの重要な要因は、ペットヘルスケアに対する保険契約の採用が増加しており、飼い主が経済的な制約を受けずに包括的な治療を選択することを奨励していることです。アジア太平洋とラテンアメリカの新興国も、可処分所得の増加、都市化、ペットケアに対する考え方の進化により、市場が大きく拡大しています。しかし、市場は価格圧力、ジェネリック医薬品との競合、抗菌剤耐性への懸念といった課題に直面しており、主要企業による継続的な技術革新と戦略的な市場ポジショニングが必要となっています。

動物用皮膚科医薬品市場の主な成長促進要因は？

動物用皮膚科医薬品市場の成長は、技術の進歩、消費者行動の変化、動物医療における用途の拡大など、いくつかの要因によってもたらされます。最も重要な促進要因の一つは、アレルギー性皮膚炎や炎症性皮膚疾患を標的かつ長期的に緩和するモノクローナル抗体やJAK阻害剤などの生物学的製剤や免疫療法への嗜好の高まりです。気候変動や環境汚染によって悪化したペットのアレルギーや皮膚疾患の有病率の上昇により、動物病院への受診が増加し、専門的な薬剤の需要が高まっています。さらに、ペットのヒューマニゼーション（人間化）の動向は、飼い主のヘルスケアへの取り組み方を変え、多くの飼い主が動物の健康を確保するため、獣医が処方する高品質の皮膚科治療薬により多くの費用をかけることを望んでいます。遠隔医療やオンライン獣医療相談の急速な拡大も、皮膚科治療へのアクセスを容易にし、飼い主が遠隔地から専門家のアドバイスや処方を受けることを可能にしています。さらに、動物用皮膚科医薬品は、皮膚病が生産性に与える経済的影響に対する意識が高まっている畜産分野でも支持を集めています。酪農家は、乳量減少、体重減少、肉質低下につながる感染症を予防するため、皮膚科治療への投資を増やしています。成長を促進するもう一つの重要な要因は、専門的治療で高度な皮膚科治療を提供する動物専門クリニックや病院の存在感が強いことです。さらに製薬会社は、犬や猫から馬や牛に至るまで、さまざまな動物のユニークな皮膚生理に対応する、種特異的な皮膚科治療薬の開発に注力しています。人工知能（AI）を搭載した画像診断・診断ツールが皮膚科疾患の早期発見を強化するため、獣医学的診断における人工知能（AI）の統合が進んでいることも、市場をさらに前進させています。最後に、ペットの飼育率の上昇と相まって、新興国での市場拡大が成長をさらに加速させ、獣医皮膚科を今後数年間の重要な投資分野とする見込みです。

セグメント

適応症（寄生虫感染症、アレルギー性感染症、その他）、タイプ（処方薬、OTC）、動物タイプ（コンパニオンアニマル、畜産動物）、投与経路（局所、経口、注射）、流通チャネル（病院薬局、小売、eコマース）

調査対象企業の例

• Bimeda, Inc.
• Bioiberica S.A.U.
• Boehringer Ingelheim
• Ceva Sante Animale
• Dechra Pharmaceuticals
• Elanco Animal Health
• Hester Biosciences Limited
• IDEXX Laboratories
• Indian Immunologicals Limited
• Leti Pharma
• Mars Petcare
• Merck Animal Health
• Novartis Animal Health
• Ourofino Saude Animal
• PetIQ, Inc.
• Phibro Animal Health Corporation
• SAVAVET
• Toray Industries
• Vetoquinol S.A.
• Vivaldis

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Veterinary Dermatology Drugs Market to Reach US$27.6 Billion by 2030

The global market for Veterinary Dermatology Drugs estimated at US$16.8 Billion in the year 2024, is expected to reach US$27.6 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Parasitic Infections, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$16.2 Billion by the end of the analysis period. Growth in the Allergic Infections segment is estimated at 9.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.6 Billion While China is Forecast to Grow at 13.2% CAGR

The Veterinary Dermatology Drugs market in the U.S. is estimated at US$4.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Veterinary Dermatology Drugs Market - Key Trends & Drivers Summarized

Why Is There a Surge in Demand for Veterinary Dermatology Drugs?

The veterinary dermatology drugs market is witnessing an unprecedented surge in demand, driven by the increasing prevalence of dermatological disorders in companion and livestock animals. Skin conditions such as allergic dermatitis, pyoderma, mange, and fungal infections are becoming more widespread, compelling pet owners and livestock farmers to seek effective treatment solutions. Factors such as heightened awareness among pet owners regarding animal health, improved access to veterinary care, and the growing trend of pet humanization have all contributed to this demand upswing. Moreover, veterinarians are increasingly diagnosing skin conditions earlier due to advancements in diagnostic tools and telemedicine platforms, which has led to a rise in prescription-based treatments. Companion animals, particularly dogs and cats, suffer from skin allergies due to environmental pollutants, food sensitivities, and parasitic infections, further escalating the demand for dermatological therapeutics. Additionally, livestock farmers are prioritizing animal welfare and productivity, recognizing that skin infections can significantly impact milk yield, meat quality, and overall animal health. This demand is further amplified by an increasing global population of pets, particularly in developed regions where pet ownership is at an all-time high. As awareness grows regarding zoonotic skin diseases, the importance of dermatological treatments in maintaining animal and human health has gained prominence. These elements combined are creating an expanding market for specialized veterinary dermatology drugs, making it a lucrative sector for pharmaceutical players.

What Are the Cutting-Edge Innovations in Veterinary Dermatology Drugs?

Pharmaceutical companies are investing heavily in research and development to introduce innovative and more effective veterinary dermatology drugs that offer enhanced therapeutic benefits. One of the most groundbreaking advancements in this field is the development of monoclonal antibody therapy, which provides targeted treatment for allergic dermatitis and atopic skin conditions in pets. Such biologic treatments have gained significant traction as they offer longer-lasting relief with fewer side effects compared to conventional corticosteroids and antihistamines. Additionally, the growing interest in novel small-molecule inhibitors, such as Janus kinase (JAK) inhibitors, is revolutionizing how inflammatory skin diseases in animals are managed. These inhibitors effectively block specific cytokine pathways involved in allergic responses, offering precision treatment with minimal adverse effects. The veterinary dermatology sector is also witnessing the rise of topical drug formulations, including medicated shampoos, sprays, and ointments infused with antimicrobial peptides and natural bioactive compounds, which enhance skin barrier protection while treating infections. Furthermore, nanotechnology-driven drug delivery systems are being explored to improve the bioavailability and efficacy of dermatological treatments. Another notable trend is the rise of probiotics and microbiome-based therapies, which aim to restore skin homeostasis by modulating microbial populations on animal skin. Advances in gene therapy and regenerative medicine, though still in experimental stages, hold promise for addressing hereditary dermatological disorders in certain dog breeds. These cutting-edge innovations reflect a paradigm shift in veterinary dermatology, shifting away from symptom management toward curative and preventative approaches.

How Are Regulatory Policies and Market Dynamics Shaping the Industry?

The regulatory landscape and market dynamics play a crucial role in shaping the growth trajectory of the veterinary dermatology drugs sector. Stringent regulations surrounding animal healthcare products, particularly in the United States and European Union, have led to increased scrutiny in drug development and approval processes. Agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose rigorous standards to ensure the safety, efficacy, and quality of veterinary pharmaceuticals. While regulatory compliance remains a challenge for many manufacturers, it also ensures that only clinically tested and well-documented treatments reach the market, enhancing consumer trust. The market dynamics are further influenced by the consolidation of veterinary pharmaceutical companies, leading to intensified competition among key industry players. Large corporations are actively acquiring smaller biotech firms specializing in dermatological solutions to expand their product portfolios and gain a competitive edge. Additionally, the rising influence of e-commerce and direct-to-consumer veterinary drug sales is changing how these products are distributed. Online veterinary pharmacies and pet healthcare platforms are making dermatology drugs more accessible to pet owners, reducing dependency on traditional veterinary clinics. Another important factor influencing market dynamics is the increasing adoption of insurance policies for pet healthcare, encouraging owners to opt for comprehensive treatments without financial constraints. Emerging economies in Asia-Pacific and Latin America are also experiencing significant market expansion due to increasing disposable incomes, urbanization, and evolving attitudes toward pet care. However, the market faces challenges such as pricing pressures, competition from generic alternatives, and concerns over antimicrobial resistance, necessitating continuous innovation and strategic market positioning by key players.

What Are the Key Growth Drivers for the Veterinary Dermatology Drugs Market?

The growth in the veterinary dermatology drugs market is driven by several factors, including technological advancements, changing consumer behavior, and expanding applications in veterinary medicine. One of the most significant drivers is the increasing preference for biologics and immunotherapies, such as monoclonal antibodies and JAK inhibitors, which provide targeted and long-lasting relief from allergic dermatitis and inflammatory skin disorders. The rising prevalence of pet allergies and dermatological conditions, exacerbated by climate change and environmental pollution, has led to increased veterinary visits and a higher demand for specialized medications. Additionally, the growing trend of pet humanization has transformed how pet owners approach healthcare, with many willing to spend more on high-quality, vet-prescribed dermatology drugs to ensure their animals’ well-being. The rapid expansion of telemedicine and online veterinary consultations has also facilitated greater accessibility to dermatological treatments, allowing pet owners to seek expert advice and prescriptions remotely. Furthermore, veterinary dermatology drugs are gaining traction in the livestock sector, where there is heightened awareness regarding the economic impact of skin diseases on productivity. Farmers are increasingly investing in dermatological treatments to prevent infections that could lead to reduced milk production, weight loss, and lower meat quality. Another significant factor driving growth is the strong presence of veterinary specialty clinics and hospitals, which offer advanced dermatology care with specialized treatments. Moreover, pharmaceutical companies are focusing on developing species-specific dermatological drugs, catering to the unique skin physiology of different animals, from dogs and cats to horses and cattle. The increasing integration of artificial intelligence (AI) in veterinary diagnostics is further propelling the market forward, as AI-powered imaging and diagnostic tools enhance the early detection of dermatological disorders. Lastly, market expansion in emerging economies, coupled with rising pet adoption rates, is expected to further accelerate growth, making veterinary dermatology a key area of investment in the coming years.

SCOPE OF STUDY:

The report analyzes the Veterinary Dermatology Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Parasitic Infections, Allergic Infections, Others); Type (Prescription, OTC); Animal Type (Companion Animals, Livestock Animals); Administration Route (Topical, Oral, Injectable); Distribution Channel (Hospital Pharmacies, Retail, E-Commerce)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Bimeda, Inc.
• Bioiberica S.A.U.
• Boehringer Ingelheim
• Ceva Sante Animale
• Dechra Pharmaceuticals
• Elanco Animal Health
• Hester Biosciences Limited
• IDEXX Laboratories
• Indian Immunologicals Limited
• Leti Pharma
• Mars Petcare
• Merck Animal Health
• Novartis Animal Health
• Ourofino Saude Animal
• PetIQ, Inc.
• Phibro Animal Health Corporation
• SAVAVET
• Toray Industries
• Vetoquinol S.A.
• Vivaldis

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Veterinary Dermatology Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Incidence of Allergic Dermatitis and Parasitic Skin Infections Throws the Spotlight on Veterinary Dermatology Treatments
  • Rising Pet Ownership and Increased Willingness to Spend on Pet Healthcare Drives Adoption of Dermatological Medications
  • Expansion of Companion Animal Clinics and Specialty Veterinary Services Expands Addressable Market Opportunity
  • Advancements in Topical, Oral, and Injectable Formulations Strengthens Business Case for Treatment Diversification
  • Surging Demand for Immunomodulators and Monoclonal Antibodies Spurs Growth in Advanced Therapeutics
  • Increase in Awareness of Zoonotic Skin Diseases Among Pet Owners Generates Accelerated Demand for Preventive Dermatology
  • Proliferation of OTC Veterinary Skincare Products Drives Market Growth in At-Home Treatment Segments
  • Rise in Chronic Skin Conditions Among Breeds With Genetic Predisposition Propels Long-Term Therapeutic Needs
  • Innovation in Hypoallergenic and Non-Steroidal Formulations Supports Demand for Safer, Long-Term Use Options
  • Veterinary Telemedicine Platforms Drive Adoption of Remote Dermatological Consultations and Drug Prescriptions
  • Emphasis on Antimicrobial Stewardship in Veterinary Practices Spurs Use of Targeted Dermatological Therapies
  • Availability of Dermatology-Specific Diagnostic Tools and Skin Biopsy Kits Enhances Clinical Decision-Making
  • Expansion of Veterinary Pharma R&D Pipelines Focused on Dermatological Molecules Boosts Product Innovation
  • Increased Use of Natural and Botanical Actives in Veterinary Skincare Products Aligns With Clean Label Trends
  • Regulatory Approvals for Biologics and Novel Small Molecules Strengthen Pipeline for Dermatology Drugs in Animals
  • Growing Focus on Quality of Life for Geriatric and Immunocompromised Pets Sustains Demand for Maintenance Therapies
  • Collaborations Between Veterinary Dermatologists and Pharmaceutical Companies Drive Evidence-Based Drug Development
  • Rising Awareness Among Livestock and Equine Owners About Skin Conditions Expands Demand Beyond Companion Animals
  • Globalization of Pet Food and Grooming Products Markets Drives Cross-Selling of Dermatology-Linked Nutraceuticals
  • Growing Incidence of Antibiotic Resistance Challenges Conventional Treatment Pathways and Drives Shift to Targeted Therapies
  • Expansion of Distribution Networks, Including Online Veterinary Pharmacies, Enhances Access to Dermatological Medications
  • Increased Regulatory Oversight and Labeling Requirements Encourage Compliance and Transparency in Dermatology Drug Manufacturing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Veterinary Dermatology Drugs Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Veterinary Dermatology Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Veterinary Dermatology Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Parasitic Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Parasitic Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Parasitic Infections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Allergic Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Allergic Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Allergic Infections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Injectable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Retail by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Retail by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Retail by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for E-Commerce by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for E-Commerce by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for E-Commerce by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Prescription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Prescription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Prescription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for OTC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for OTC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for OTC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Livestock Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Canada 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• JAPAN
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Japan 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• CHINA
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 89: China Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: China 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: China 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• EUROPE
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Veterinary Dermatology Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Veterinary Dermatology Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Europe 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• FRANCE
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 122: France Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: France 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 125: France Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: France 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: France 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: France 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: France 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• GERMANY
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Germany 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Germany 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Germany 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Germany 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 149: Germany Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Germany Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Germany 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Italy 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Italy 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Italy 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 161: Italy Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Italy Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Italy 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 164: Italy Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Italy Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Italy 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 167: UK Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: UK 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: UK 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 173: UK Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: UK Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: UK 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 176: UK Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: UK Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: UK 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 179: UK Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: UK Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: UK 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Spain 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 185: Spain Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Spain Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Spain 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 188: Spain Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Spain Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Spain 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 191: Spain Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Spain Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Spain 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 194: Spain Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Spain Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Spain 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 197: Russia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Russia Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Russia 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 200: Russia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Russia Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Russia 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 203: Russia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Russia Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Russia 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 206: Russia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Russia Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Russia 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 209: Russia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Russia Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Russia 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Rest of Europe Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Rest of Europe 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 215: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Rest of Europe Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Rest of Europe 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 218: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Rest of Europe Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Rest of Europe 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 221: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Rest of Europe Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Rest of Europe 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Europe Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Rest of Europe 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 228: Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 230: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 233: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 236: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 245: Australia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Australia Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Australia 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 248: Australia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Australia Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Australia 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 251: Australia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Australia Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Australia 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 254: Australia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Australia Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Australia 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 257: Australia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Australia Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Australia 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• INDIA
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 260: India Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: India Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: India 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 263: India Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: India Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: India 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 266: India Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: India Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: India 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 269: India Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: India Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: India 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 272: India Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: India Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: India 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 275: South Korea Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: South Korea Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: South Korea 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 278: South Korea Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: South Korea Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: South Korea 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 281: South Korea Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: South Korea Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: South Korea 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 284: South Korea Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: South Korea Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: South Korea 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 287: South Korea Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: South Korea Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: South Korea 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 290: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Asia-Pacific Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Asia-Pacific 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 305: Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 306: Latin America Historic Review for Veterinary Dermatology Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 308: Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Latin America Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 311: Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Latin America Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 314: Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Latin America Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 317: Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Latin America Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 320: Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Latin America Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 323: Argentina Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Argentina Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Argentina 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 326: Argentina Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Argentina Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Argentina 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 329: Argentina Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Argentina Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Argentina 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 332: Argentina Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Argentina Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Argentina 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 335: Argentina Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Argentina Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Argentina 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 338: Brazil Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Brazil Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Brazil 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 341: Brazil Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Brazil Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Brazil 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 344: Brazil Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Brazil Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Brazil 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 347: Brazil Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Brazil Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Brazil 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 350: Brazil Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Brazil Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Brazil 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 353: Mexico Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Mexico Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Mexico 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 356: Mexico Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Mexico Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Mexico 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 359: Mexico Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Mexico Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Mexico 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 362: Mexico Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Mexico Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Mexico 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 365: Mexico Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Mexico Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Mexico 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 368: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Rest of Latin America Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Rest of Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 371: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Rest of Latin America Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Rest of Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 374: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Latin America Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Latin America Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Latin America Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Latin America 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 383: Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 384: Middle East Historic Review for Veterinary Dermatology Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 386: Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Middle East Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 389: Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Middle East Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 392: Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Middle East Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 395: Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Middle East Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 398: Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Middle East Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 401: Iran Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Iran Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Iran 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 404: Iran Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Iran Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Iran 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 407: Iran Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Iran Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Iran 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 410: Iran Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Iran Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Iran 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 413: Iran Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Iran Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Iran 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 416: Israel Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Israel Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Israel 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 419: Israel Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Israel Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Israel 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 422: Israel Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Israel Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Israel 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 425: Israel Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Israel Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Israel 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 428: Israel Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Israel Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 430: Israel 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 431: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Saudi Arabia Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 433: Saudi Arabia 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 434: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Saudi Arabia Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 436: Saudi Arabia 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 437: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Saudi Arabia Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 439: Saudi Arabia 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 440: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Saudi Arabia Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 442: Saudi Arabia 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 443: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Saudi Arabia Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 445: Saudi Arabia 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 446: UAE Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: UAE Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 448: UAE 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 449: UAE Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: UAE Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 451: UAE 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 452: UAE Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: UAE Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 454: UAE 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 455: UAE Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: UAE Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 457: UAE 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 458: UAE Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: UAE Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 460: UAE 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 461: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: Rest of Middle East Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 463: Rest of Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 464: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: Rest of Middle East Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 466: Rest of Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 467: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: Rest of Middle East Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 469: Rest of Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 470: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: Rest of Middle East Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 472: Rest of Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 473: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: Rest of Middle East Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 475: Rest of Middle East 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• AFRICA
  • Veterinary Dermatology Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 476: Africa Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: Africa Historic Review for Veterinary Dermatology Drugs by Indication - Parasitic Infections, Allergic Infections and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 478: Africa 15-Year Perspective for Veterinary Dermatology Drugs by Indication - Percentage Breakdown of Value Sales for Parasitic Infections, Allergic Infections and Others for the Years 2015, 2025 & 2030
  • TABLE 479: Africa Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: Africa Historic Review for Veterinary Dermatology Drugs by Administration Route - Injectable, Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 481: Africa 15-Year Perspective for Veterinary Dermatology Drugs by Administration Route - Percentage Breakdown of Value Sales for Injectable, Topical and Oral for the Years 2015, 2025 & 2030
  • TABLE 482: Africa Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: Africa Historic Review for Veterinary Dermatology Drugs by Distribution Channel - Hospital Pharmacies, Retail and E-Commerce Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 484: Africa 15-Year Perspective for Veterinary Dermatology Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail and E-Commerce for the Years 2015, 2025 & 2030
  • TABLE 485: Africa Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: Africa Historic Review for Veterinary Dermatology Drugs by Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 487: Africa 15-Year Perspective for Veterinary Dermatology Drugs by Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2015, 2025 & 2030
  • TABLE 488: Africa Recent Past, Current & Future Analysis for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Africa Historic Review for Veterinary Dermatology Drugs by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 490: Africa 15-Year Perspective for Veterinary Dermatology Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030

IV. COMPETITION